Adolor Corporation

Biopharmaceutical company reports loss of $0.22 per share

Published in Elder Law Weekly, December 1st, 2004

Adolor Corporation (ADLR) reported financial results for the 3 and 9 months ended September 30, 2004.

For the 3 months ended September 30, 2004, the company reported a net loss of $8.7 million or $0.22 per basic and diluted share, compared to a net loss of $13.8 million or $0.44 per basic and diluted share in the 3 months ended September 30, 2003.

For the 9 month period ended September 30, 2004, the company reported a net loss of $32.0 million or $0.82 per basic and diluted share, compared to a net loss of $36.7 million or $1.16 per basic and diluted share for the same period in 2003.

"The third quarter was highlighted by the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Elder Law Weekly

Source: Elder Law Weekly (2004-12-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry